7OC.DU - ONCOCYTE CORP.

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2018
31/12/2017
31/12/2016
31/12/2015
Total revenue
0
0
-
-
-
Cost of revenue
-
-
-
-
-
Gross profit
-
-
-
-
-
Operating expenses
Research development
5,581
6,514
7,174
5,677
4,527
Selling general and administrative
10,947
8,688
11,675
5,463
4,191
Total operating expenses
16,528
15,202
18,849
11,140
8,718
Operating income or loss
-16,528
-15,202
-18,849
-11,140
-8,718
Interest expense
-
-
-
-
-
Total other income/expenses net
-237
-336
-309
0
2
Income before tax
-16,717
-15,754
-19,375
-11,168
-8,735
Income tax expense
-
-
-
-
-
Income from continuing operations
-16,717
-15,754
-19,375
-11,168
-8,735
Net income
-16,717
-15,754
-19,375
-11,168
-8,735
Net income available to common shareholders
-16,717
-15,754
-19,375
-11,168
-8,735
Reported EPS
Basic
-
-0.42
-0.64
-0.42
-0.42
Diluted
-
-0.42
-0.64
-0.42
-0.42
Weighted average shares outstanding
Basic
-
37,850
30,195
26,529
21,009
Diluted
-
37,850
30,195
26,529
21,009
EBITDA
-
-14,643
-18,269
-11,140
-8,718
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more